This is a StreetInsider.com Premium Only Page

AmpliPhi Biosciences (APHB) –

Dec 22, 2022 08:00 AM Armata Pharmaceuticals Announces Completion of its Phase 1b/2a 'SWARM-P.a.' Study of Inhaled AP-PA02 in Cystic Fibrosis Subjects with Chronic Pulmonary Pseudomonas aeruginosa Infection

Nov 28, 2022 08:00 AM Armata Pharmaceuticals to Participate in the H.C. Wainwright 1st Annual Investor Conference on Bacteriophage

Jan 5, 2022 08:00 AM Armata Pharmaceuticals Provides Update on Pseudomonas Respiratory Programs

Nov 18, 2021 08:10 AM Armata Pharma (ARMP) Provides Regulatory and Clinical Update Reflecting Sustained Progress Across Key Phage Therapeutic Development Programs

Nov 18, 2021 08:00 AM Armata Pharmaceuticals Provides Regulatory and Clinical Update Reflecting Sustained Progress Across Key Phage Therapeutic Development Programs

Nov 4, 2021 08:00 AM Armata Pharmaceuticals to Present at the 2021 World Antimicrobial Resistance Congress

Oct 28, 2021 06:41 PM Cystic Fibrosis Foundation Makes Equity Investment in Armata Pharmaceuticals

Jul 7, 2021 07:30 AM Armata Pharmaceuticals to Present at the Ladenburg Thalmann 2021 Healthcare Conference

Jan 27, 2021 07:01 AM Armata Pharmaceuticals Announces $20 Million Investment to Support Advancement of the Company's Bacteriophage Development Programs

Dec 9, 2020 07:34 AM Armata Pharma (ARMP) Adds Robin C. Kramer to Board

Dec 9, 2020 07:30 AM Armata Pharmaceuticals Announces the Addition of Robin C. Kramer to its Board of Directors

Sep 11, 2020 07:30 AM Armata Pharmaceuticals Announces Participation in Upcoming Investor Conferences

May 10, 2019 05:17 PM Form SC 13G Armata Pharmaceuticals, Filed by: DELTA DENTAL OF CALIFORNIA

May 10, 2019 04:39 PM Form 8-K Armata Pharmaceuticals, For: May 09

May 8, 2019 04:22 PM Form 8-K AmpliPhi Biosciences For: May 08

May 8, 2019 04:17 PM AmpliPhi Biosciences Announces Stockholder Approval of Business Combination with C3J Therapeutics

May 6, 2019 04:30 PM AmpliPhi Biosciences Reports First Quarter 2019 Financial Results and Business Highlights

May 6, 2019 04:18 PM Form 10-Q AmpliPhi Biosciences For: Mar 31

May 1, 2019 06:06 AM Form DEFA14A AmpliPhi Biosciences

Apr 15, 2019 04:07 PM Form DEFA14A AmpliPhi Biosciences

Apr 4, 2019 08:02 AM Form DEFM14A AmpliPhi Biosciences

Apr 2, 2019 05:00 AM C3J Therapeutics Announces Issuance of U.S. Patent Covering Synthetic Bacteriophage

Mar 25, 2019 09:01 AM AmpliPhi Biosciences Reports Fourth Quarter and Full Year 2018 Financial Results and Business Highlights

Mar 25, 2019 08:48 AM Form PREM14A AmpliPhi Biosciences For: May 08

Mar 25, 2019 08:34 AM Form 10-K AmpliPhi Biosciences For: Dec 31

Feb 7, 2019 08:01 AM Form 8-K AmpliPhi Biosciences For: Feb 05

Jan 30, 2019 03:37 PM Form SC 13G/A AmpliPhi Biosciences Filed by: Hudson Bay Capital Management LP

Jan 15, 2019 06:13 AM Form 8-K AmpliPhi Biosciences For: Jan 14

Jan 14, 2019 05:03 PM Form 8-K AmpliPhi Biosciences For: Jan 14

Jan 14, 2019 05:02 PM Form DEFA14A AmpliPhi Biosciences

Jan 10, 2019 01:26 PM Form SC 13G/A AmpliPhi Biosciences Filed by: Empery Asset Management, LP

Jan 7, 2019 08:02 AM Form 8-K AmpliPhi Biosciences For: Jan 07

Jan 4, 2019 05:12 PM Form DEFA14A AmpliPhi Biosciences

Jan 4, 2019 05:10 PM Form 8-K AmpliPhi Biosciences For: Jan 03

Jan 4, 2019 11:17 AM Form SC 13G/A AmpliPhi Biosciences Filed by: SABBY MANAGEMENT, LLC

Jan 4, 2019 08:04 AM AmpliPhi Biosciences (APHB) Announces Merger Agreement with C3J Therapeutics

Jan 4, 2019 08:00 AM AmpliPhi Biosciences and C3J Therapeutics Agree to Merge

Dec 18, 2018 08:31 AM Form 8-K AmpliPhi Biosciences For: Dec 17

Dec 18, 2018 06:50 AM AmpliPhi Biosciences Successfully Optimizes Manufacturing Process and Scale Up for AB-SA01 Clinical Development

Nov 23, 2018 08:25 AM Analysis: Positioning to Benefit within Artisan Partners Asset Management, Gamco Investors, Eiger BioPharmaceuticals, Waddell & Reed Financial, AmpliPhi Biosciences, and Limbach — Research Highl

Nov 9, 2018 08:01 AM Form DEF 14A AmpliPhi Biosciences For: Dec 17

Nov 8, 2018 04:10 PM AmpliPhi Biosciences Reports Third Quarter 2018 Financial Results and Business Highlights

Nov 8, 2018 04:04 PM Form 10-Q AmpliPhi Biosciences For: Sep 30

Oct 26, 2018 04:19 PM Form PRE 14A AmpliPhi Biosciences For: Dec 17

Oct 19, 2018 11:18 AM UPDATE: AmpliPhi Biosciences (APHB) PT Lowered to $3.50 at H.C. Wainwright

Oct 17, 2018 06:05 AM Camallergy Appoints Baxter Phillips III as Chief Executive Officer

Oct 16, 2018 04:10 PM AmpliPhi Biosciences Announces Closing of Public Offering

Oct 16, 2018 04:07 PM Form 8-K AmpliPhi Biosciences For: Oct 12

Oct 15, 2018 04:46 PM Form 424B4 AmpliPhi Biosciences

Oct 12, 2018 06:06 AM Form POS EX AmpliPhi Biosciences